Table 1.
Total (n=768) | ER+ (n=447) | ER−, Nonbasal (n=193) | ER−, Basal (n=128) | P Value | |||||
---|---|---|---|---|---|---|---|---|---|
Patient age | |||||||||
Median | 65 | 68 | 56 | 57.5 | |||||
Tumor grade | # cases | % | # cases | % | # cases | % | # cases | % | |
0-5 | 34 | 6 | 21 | 6 | 9 | 7 | 4 | 8 | <.0001 |
6-7 | 362 | 66 | 298 | 82 | 53 | 39 | 11 | 23 | |
8-10 | 151 | 28 | 44 | 12 | 74 | 54 | 33 | 69 | |
Nodal status | |||||||||
+ve | 356 | 46.8% | 204 | 45.6% | 92 | 48.8% | 60 | 48.4% | .7275 |
−ve | 404 | 53.2% | 243 | 54.4% | 98 | 51.2% | 63 | 51.6% | |
Tumor size | |||||||||
>2.5 cm | 301 | 48% | 195 | 45% | 26 | 50% | 80 | 56% | .0589 |
<=2.5 cm | 331 | 52% | 242 | 55% | 26 | 50% | 63 | 44% | |
Claudin 1 (H-score) | # cases | median | # cases | median | # cases | median | # cases | median | <.0001 |
643 | 30 | 371 | 15 | 164 | 70 | 108 | 62.50 | ||
PKCα (intensity) | # cases | % | # cases | % | # cases | % | # cases | % | |
1 | 387 | 73.6% | 307 | 73.6% | 31 | 77.5% | 49 | 71.0% | .7595 |
2, 3 | 139 | 26.4% | 110 | 26.4% | 9 | 22.5% | 20 | 29.0% | |
PKCε (intensity) | # cases | % | # cases | % | # cases | % | # cases | % | |
1 | 449 | 69.0% | 259 | 64.9% | 112 | 71.8% | 78 | 81.3% | <.01 |
2, 3 | 202 | 31.0% | 140 | 35.1% | 44 | 28.2% | 18 | 18.8% | |
Recurrence (5 years) | 32.0% | 22.8% | 50.3% | 37.5% | <.001 | ||||
Survival (5 years) | 76.5% | 89.0% | 54.5% | 65.4% |